USE OF ALBIFLORIN OR PAEONIFLORIN IN THE PREVENTION AND/OR TREATMENT OF RENAL ANEMIA

摘要

Use of albiflorin, paeoniflorin or a composition containing albiflorin or paeoniflorin in the preparation of drugs, healthcare products, food nutritional agents or food additives for increasing endogenous erythropoietin; and use of albiflorin, paeoniflorin or a composition containing albiflorin or paeoniflorin in the preparation of drugs, healthcare products, food nutritional agents or food additives for preventing and/or treating primary anemia, secondary anemia or renal anemia by increasing endogenous erythropoietin. Albiflorin and paeoniflorin are derived from Radix Paeoniae Alba having medicine and food homology, and are naturally occurring single agents. Compared with other compound drugs in the prior art, higher safety and patient compliance are achieved.